Sequoia Financial Advisors LLC Has $5.26 Million Holdings in Intuitive Surgical, Inc. $ISRG

Sequoia Financial Advisors LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,684 shares of the medical equipment provider’s stock after buying an additional 1,097 shares during the period. Sequoia Financial Advisors LLC’s holdings in Intuitive Surgical were worth $5,263,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in ISRG. Norway Savings Bank increased its position in shares of Intuitive Surgical by 53.4% during the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after purchasing an additional 910 shares during the last quarter. IronOak Wealth LLC. bought a new position in Intuitive Surgical during the 2nd quarter worth $1,099,000. Trust Co. of Oklahoma bought a new position in Intuitive Surgical during the 2nd quarter worth $363,000. Neville Rodie & Shaw Inc. lifted its position in shares of Intuitive Surgical by 11.9% during the 2nd quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after acquiring an additional 1,110 shares during the period. Finally, Sax Wealth Advisors LLC lifted its position in shares of Intuitive Surgical by 218.1% during the 2nd quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock valued at $1,334,000 after acquiring an additional 1,684 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.2%

ISRG stock opened at $436.39 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The firm has a market cap of $156.44 billion, a PE ratio of 60.86, a price-to-earnings-growth ratio of 4.58 and a beta of 1.61. The business has a 50 day moving average of $456.92 and a 200 day moving average of $497.02.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.78 EPS. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amy L. Ladd sold 336 shares of the business’s stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares in the company, valued at $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 45,224 shares of company stock worth $21,716,492. Corporate insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on ISRG shares. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, October 4th. Truist Financial increased their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 23rd. Finally, BTIG Research dropped their target price on Intuitive Surgical from $571.00 to $529.00 and set a “buy” rating for the company in a report on Monday. Fourteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $585.71.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.